112 related articles for article (PubMed ID: 30037211)
1. Role of Holmium laser enucleation of the prostate to increase cancer detection rate in patients with gray-zone PSA level.
Kim KH; Kim SW; Son HS; Kim DK; Jung DC; Kim HW; Kim JC; Hong SJ; Kim JH
Minerva Urol Nefrol; 2019 Feb; 71(1):72-78. PubMed ID: 30037211
[TBL] [Abstract][Full Text] [Related]
2. Coexisting prostate cancer found at the time of holmium laser enucleation of the prostate for benign prostatic hyperplasia: predicting its presence and grade in analyzed tissue.
Bhojani N; Boris RS; Monn MF; Mandeville JA; Lingeman JE
J Endourol; 2015 Jan; 29(1):41-6. PubMed ID: 25046691
[TBL] [Abstract][Full Text] [Related]
3. Changes in serum PSA after endoscopic enucleation of the prostate are predictive for the future diagnosis of prostate cancer.
Lambert E; Goossens M; Palagonia E; Vollemaere J; Mazzone E; Dell'Oglio P; Pauwels E; De Groote R; D'Hondt F; Mottrie A; De Naeyer G; Schatteman P
World J Urol; 2021 Jul; 39(7):2621-2626. PubMed ID: 32997261
[TBL] [Abstract][Full Text] [Related]
4. Incidental prostate cancer after holmium laser enucleation of the prostate: incidence and predictive factors for clinical progression.
Klein C; Marquette T; Capon G; Yacoub M; Alezra E; Bernhard JC; Bladou F; Robert G
Int J Clin Oncol; 2022 Jun; 27(6):1077-1083. PubMed ID: 35333999
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer detected after Holmium laser enucleation of prostate (HoLEP): significance of transrectal ultrasonography.
Kim M; Song SH; Ku JH; Oh SJ; Paick JS
Int Urol Nephrol; 2014 Nov; 46(11):2079-85. PubMed ID: 24980863
[TBL] [Abstract][Full Text] [Related]
6. Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy.
Elmansy HM; Elzayat EA; Sampalis JS; Elhilali MM
Urology; 2009 Nov; 74(5):1105-10. PubMed ID: 19773035
[TBL] [Abstract][Full Text] [Related]
7. Significance of prostate-specific antigen-related factors in incidental prostate cancer treated by holmium laser enucleation of the prostate.
Otsubo S; Yokomizo A; Mochida O; Shiota M; Tatsugami K; Inokuchi J; Naito S
World J Urol; 2015 Mar; 33(3):329-33. PubMed ID: 24804843
[TBL] [Abstract][Full Text] [Related]
8. HoLEP provides a higher prostate cancer detection rate compared to bipolar TURP: a matched-pair analysis.
Rosenhammer B; Lausenmeyer EM; Mayr R; Burger M; Eichelberg C
World J Urol; 2018 Dec; 36(12):2035-2041. PubMed ID: 29858700
[TBL] [Abstract][Full Text] [Related]
9. Holmium laser enucleation of the prostate and perioperative diagnosis of prostate cancer: an outcomes analysis.
Rivera ME; Frank I; Viers BR; Rangel LJ; Krambeck AE
J Endourol; 2014 Jun; 28(6):699-703. PubMed ID: 24484284
[TBL] [Abstract][Full Text] [Related]
10. Holmium Laser Enucleation of the Prostate Provides Similar Incidental Prostate Cancer Detection Rates as Open Prostatectomy: A Matched Pair Analysis.
Rosenhammer B; Lausenmeyer EM; Mayr R; Burger M; Eichelberg C
Urol Int; 2018; 101(4):382-386. PubMed ID: 30235460
[TBL] [Abstract][Full Text] [Related]
11. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
[TBL] [Abstract][Full Text] [Related]
12. Comorbidities as predictors of incidental prostate cancer after Holmium laser enucleation of the prostate: diabetes and high-risk cancer.
Ohwaki K; Endo F; Shimbo M; Fujisaki A; Hattori K
Aging Male; 2017 Dec; 20(4):257-260. PubMed ID: 28332895
[TBL] [Abstract][Full Text] [Related]
13. Reoperation After Holmium Laser Enucleation of the Prostate for Management of Benign Prostatic Hyperplasia: Assessment of Risk Factors with Time to Event Analysis.
Elkoushy MA; Elshal AM; Elhilali MM
J Endourol; 2015 Jul; 29(7):797-804. PubMed ID: 25705817
[TBL] [Abstract][Full Text] [Related]
14. Change in serum prostate specific antigen concentration after holmium laser enucleation of the prostate: a marker for completeness of adenoma resection?
Tinmouth WW; Habib E; Kim SC; Kuo RL; Paterson RF; Terry CL; Elhilali M; Lingeman JE
J Endourol; 2005 Jun; 19(5):550-4. PubMed ID: 15989443
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy using a low-powered holmium laser for enucleation of the prostate (HoLEP): 12-month results from a prospective low-power HoLEP series.
Becker B; Gross AJ; Netsch C
World J Urol; 2018 Mar; 36(3):441-447. PubMed ID: 29275506
[TBL] [Abstract][Full Text] [Related]
16. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Holmium Laser Enucleation and Plasmakinetic Resection of Prostate: A Randomized Trial with 72-Month Follow-Up.
Gu M; Chen YB; Liu C; Wan X; Cai ZK; Chen Q; Wang Z
J Endourol; 2018 Feb; 32(2):139-143. PubMed ID: 29239228
[TBL] [Abstract][Full Text] [Related]
18. Prostatic Arterial Embolization Followed by Holmium Laser Enucleation of the Prostate as a Planned Combined Approach for Extremely Enlarged Benign Prostate Hyperplasia.
Li P; Wang C; Cao Q; Zhang J; Shi H; Meng X
Urol Int; 2017; 99(4):422-428. PubMed ID: 28768261
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
Elshal AM; Elmansy HM; Elhilali MM
BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
[TBL] [Abstract][Full Text] [Related]
20. Holmium laser enucleation (HoLEP) and photoselective vaporisation of the prostate (PVP) for patients with benign prostatic hyperplasia (BPH) and chronic urinary retention.
Jaeger CD; Mitchell CR; Mynderse LA; Krambeck AE
BJU Int; 2015 Feb; 115(2):295-9. PubMed ID: 24552209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
